We have continued our study of the insulin-like growth factor/somatomedin, rat IGF-II, a polypeptide synthesized by a cloned line of rat liver cells (BRL-3A). During the past year, progress has been made in the following areas: (1) determination of the structure of pre-pro-rIGF-II and pro-rIGF-II by molecular cloning and radiosequencing; (2) demonstration that IGF-II mRNA levels are high in fetal and neonatal rat liver and decrease in adult tissues, suggesting that the developmental regulation of IGF-II may occur at the level of transcription; (3) demonstration that the major IGF-II RNA is 4 kilobases, considerably larger than the functional 1.2 kb IGF-II RNA used to establish our cDNA library; (4) demonstration that the 4 kb IGF-II RNA does not direct translation of pre-pro-rIGF-II, and may require further processing to become activated; (5) demonstration that growth hormone regulates the abundance of IGF-I mRNA in adult rat liver, suggesting possible transcriptional regulation; (6) demonstration that the tyrosine kinase activity of the Beta-subunit of the type I IGF receptor closely resembles that of the insulin receptor, suggesting that the homologies between the two receptors extends to their kinase domains; (7) development of antibodies to the Mr 40,000 IGF carrier protein in neonatal rat serum, and demonstrating that it is immunologically distinct from the Mr 150,000 carrier protein in adult rat serum; (8) demonstration that chemically synthesized hybrid molecules containing the A-chain of insulin and the Beta-domain of IGF-I bind with enhanced affinity to IGF carrier proteins; and (9) demonstration using these hybrid molecules that IGF carrier proteins synthesized by cultured human fibroblasts modulate the binding of IGF-I to IGF receptors on cell monolayers.

Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1986
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Adams, Ted D; Davidson, Lance E; Litwin, Sheldon E et al. (2017) Weight and Metabolic Outcomes 12 Years after Gastric Bypass. N Engl J Med 377:1143-1155
Adams, Ted D; Davidson, Lance E; Litwin, Sheldon E et al. (2012) Health benefits of gastric bypass surgery after 6 years. JAMA 308:1122-31
Kolotkin, Ronette L; Davidson, Lance E; Crosby, Ross D et al. (2012) Six-year changes in health-related quality of life in gastric bypass patients versus obese comparison groups. Surg Obes Relat Dis 8:625-33
Hammoud, Ahmad O; Walker, James M; Gibson, Mark et al. (2011) Sleep apnea, reproductive hormones and quality of sexual life in severely obese men. Obesity (Silver Spring) 19:1118-23
Kolotkin, Ronette L; LaMonte, Michael J; Litwin, Sheldon et al. (2011) Cardiorespiratory fitness and health-related quality of life in bariatric surgery patients. Obes Surg 21:457-64
Wasmund, Stephen L; Owan, Theophilus; Yanowitz, Frank G et al. (2011) Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study. Heart Rhythm 8:84-90
Hunt, Steven C; Hasstedt, Sandra J; Xin, Yuanpei et al. (2011) Polymorphisms in the NPY2R gene show significant associations with BMI that are additive to FTO, MC4R, and NPFFR2 gene effects. Obesity (Silver Spring) 19:2241-7
Benraouane, Fethi; Litwin, Sheldon E (2011) Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol 26:555-61
Adams, Ted D; Pendleton, Robert C; Strong, Michael B et al. (2010) Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity (Silver Spring) 18:121-30
Hammoud, Ahmad; Carrell, Douglas T; Meikle, A Wayne et al. (2010) An aromatase polymorphism modulates the relationship between weight and estradiol levels in obese men. Fertil Steril 94:1734-8

Showing the most recent 10 out of 22 publications